Switch Language

Nos membres

COVANCE CENTRAL LABORATORY SERVICES

Covance Inc., a global contract research organization (CRO), is the world’s most comprehensive drug development company.Covance Inc., the drug development business of LabCorp®, is the world’s most comprehensive drug development company, dedicated to advancing healthcare and delivering Solutions Made Real®. Our unique perspectives, built from decades of scientific expertise and precision delivery of the largest volume of drug development data in the world, along with our innovative technology solutions, help our clients identify new approaches and anticipate tomorrow’s challenges as they evolve.

DRUGDESIGNTECH

Drugdesigntech develops innovative computational solutions to support drug discovery, with a focus on knowledge management and decision support for both biologic therapeutics and traditional small molecule drug discovery. The company was founded in 2007 by Cédric Merlot and is based at the Eclosion incubator centre in Geneva, Switzerland.

DUPONT DE NEMOURS INTERNATIONAL

Originally a chemical company, DuPont de Nemours has since begun its transformation to offer a wide range of innovative products in the fields of agriculture and food, construction, communication, transportation and renewable energies. Having identified several macro-trends such as the need to increase global food production, decreasing dependence on fossil fuels, protecting lives and the environment, and growth in developing countries, society focuses its research and development activities on technologies that meet these needs.

F. UHLMANN-EYRAUD

The company Uhlmann Eyraud S.A. sells medicinal and bodycare products that are available without a prescription. The company occupies a unique position in the sector thanks to its access to all sales points throughout Switzerland, its numerous relationships with retailers and experts, its sustainable customer relationships and its product expertise.

FIRMENICH

Firmenich is the largest private company in the perfume and flavor industry. Founded in Geneva in 1895, it is at the origin of a long list of great classics of fine perfumery and aromas that you enjoy every day. His passion for perfumes and aromas is at the heart of his success. She is renowned for her creativity, her ability to innovate, and her exceptional understanding of market trends. Every year, it invests about 10% of its turnover in research, reflecting its constant desire to understand, share and sublimate what nature offers.

GENEURO

GeNeuro is a clinical stage pharmaceutical company developing a new approach to the treatment of autoimmune diseases, including multiple sclerosis (MS) and Type 1 Diabetes (T1D) associated with pathogenic proteins expressed by human endogenous retroviruses (HERV), viral genes that account for 8% of human DNA. This novel approach is the result of 25 years of research on endogenous retroviruses, including 15 within Institut Mérieux and INSERM, before the creation of GeNeuro in 2006.

GENKYOTEX

Genkyotex is the leading biopharmaceutical company in NOX therapies, listed on the Euronext Paris and Euronext Brussels markets. A leader in NOX therapies, its unique therapeutic approach is based on a selective inhibition of NOX enzymes that amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration.

GIVAUDAN

Givaudan is the global leader in the creation of flavours and fragrances. In close collaboration with food, beverage, consumer product and fragrance partners, Givaudan develops tastes and scents that delight consumers the world over. With a passion to understand consumers’ preferences and a relentless drive to innovate, Givaudan is at the forefront of creating flavours and fragrances that ‘engage your senses’. The Company achieved sales of CHF 5.5 billion in 2018. Headquartered in Geneva with local presence in over 145 locations, the Company has almost 13,600 employees worldwide.

LABATEC PHARMA

As a private company based in Switzerland, Labatec is a pharmaceutical company with more than 50 years of experience in the production and marketing of high quality pharmaceutical products. Labatec develops and markets medicines that help improve the quality of life of patients around the world, in perfect synergy with the needs of the hospital and retail sectors. Made in Europe and approved by Swissmedic, products represent a trusted European pharmaceutical brand.

MERCK SERONO

The Merck Group, branded and commonly known as Merck, is a German multinational pharmaceutical, chemical and life sciences company headquartered in Darmstadt, with around 50,000 employees in around 70 countries. Merck was founded in 1668 and is the world’s oldest operating chemical and pharmaceutical company, as well as one of the largest pharmaceutical companies in the world.Merck operates in Europe, Africa, Asia, Oceania and the Americas. It has major research and development centres in Darmstadt, Boston, Tokyo and Beijing.

OM PHARMA

OM Pharma is a Swiss Biotech Pharma company fully integrated within Vifor Pharma. Founded in 1937 in Geneva, the company manufactures and distributes innovative products based on immumo modulation concept to prevent Respiratory Tract and Urinary Tract infections. The company has an historical international footprint more specifically in emerging market i.e. Latin America, China or Russia.

PREXTON THERAPEUTICS

Recently founded in Geneva, Switzerland, Prexton Therapeutics is developing novel mGluR4 PAM series, which were originally developed by Merck Serono, an affiliate of Merck KGaA in Darmstadt, Germany. The company believes that these compounds represent a unique opportunity to build a high quality development pipeline of therapeutics for Parkinson’s disease.

QUARTZ BIO

Quartz Bio is a Swiss-based company providing clinical bioinformatics services to the health sector. They use computational tools and biotechnological knowledge to analyse biomarker data from clinical trials. Their services are aimed at identifying subjects who will respond better to drugs, uncovering clinical biomarkers of interest and better understanding underlying disease mechanisms.

SELEXIS

Selexis SA, A JSR Life Sciences Company, is the global leader in cell line development with best-in-class modular technology and highly specialized solutions that enable the life sciences industry to rapidly discover, develop and commercialize innovative medicines and vaccines.

UCB FARCHIM

UCB is a global biopharma company, focusing on neurology and immunology. Our business is strong. Total revenue grew to €4.6 billion in 2018. We are around 7,500 people in all four corners of the globe, inspired by patients and driven by science.